Short-Term exposure of umbilical cord blood CD34+ cells to human platelet lysate and cytokines enhances engraftment.

Marie-Ève RhéaumePascal RouleauTony TremblayIsabelle ParéLionel Loubaki

Published in: Transfusion (2020)

The use of hPL + cytokines as a short-term priming treatment for UCB could be an advantageous strategy to improve clinical outcomes following IBM injection.

Keyphrases

umbilical cord
mesenchymal stem cells
induced apoptosis
endothelial cells
endoplasmic reticulum stress
signaling pathway
bone marrow
cell proliferation
cell death